Background Many trials have proved the benefits of early systematic treatment with
angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction (AMI) …

Abstract< A positive history of arterial hypertension (HBP) is present in as many as 30% of
patients with acute myocardial infarction (AMI) and their clinical outcome could be greatly …

Angiotensin-converting enzyme (ACE) inhibitor therapy has been associated with a
substantial (≥ 20%) reduction in the risk of major ischemic events in two recent clinical trials …

A number of major studies have examined the impact of angiotensin-converting enzyme
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …

Objective To evaluate the influence of a history of arterial hypertension and the level of
pretreatment blood pressure on the efficacy of the angiotensin converting enzyme (ACE) …

Objective To evaluate the influence of a history of arterial hypertension on the efficacy of the
angiotensin converting enzyme (ACE) inhibitor trandolapril in patients with acute myocardial …

This review summarizes the evidence from five of the larger randomized controlled trials
evaluating the effects of angiotensin converting enzyme inhibitors started in the early phase …

Angiotensin II (ATII) levels are elevated in the myocardium after myocardial damage
independent of serum levels [1]. ATII results in an increase NAD (P) H vascular oxidase, the …

Angiotensin-converting enzyme (ACE) inhibitors are now established drugs in the treatment
of hypertension and heart failure. However, their use in patients after a myocardial infarction …

BACKGROUND: The causes of death occurring in clinical trials of myocardial infarction (MI)
are scarcely reported in the literature. The present analysis is aimed to describe the …